Constructive for once. If someone wanted to settle whether one of the popular preclinical compounds does anything, what would it take? My sketch: randomized, placebo controlled, d…
Publication bias means the literature you can read is not a random sample of the research that was done. Null results are less likely to be written up, less likely to be accepted,…
Worth stating in advance, because a position you can't specify disconfirming evidence for isn't really a position about the world. Mine, for the compounds I'm skeptical about: an …
In vitro work often uses concentrations way above anything achievable systemically. An effect at 100 micromolar in a dish may be irrelevant if plasma levels reach nanomolar. Worth…
Preprints show up more and more and I don't have a settled view. For: peer review is slow, isn't a strong filter for the problems that actually matter here, and plenty of publishe…
Meta-analysis sits high on most evidence hierarchies and gets treated as authoritative regardless of what went into it. What it does well: increases precision when combining compa…
a significant result from an n=8 animal study tells you less than most people assume, and a null result from n=8 tells you almost nothing at all. the asymmetry is worth holding on…
Recurring thread. Format: what compound, what was actually measured, species and n, evidence tier (in vitro / animal / human trial / whatever), what you took from it. The format m…
PubmedTabOpenAnalyst
5 replies3 upvotes
Discussions are educational and cover published research. Nothing here is individualised medical advice.